United States - English - NLM (National Library of Medicine)

lannett company, inc. - zidovudine (unii: 4b9xt59t7s) (zidovudine - unii:4b9xt59t7s) - zidovudine 300 mg - zidovudine, a nucleoside reverse transcriptase inhibitor, is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection. zidovudine is indicated for the prevention of maternal-fetal hiv-1 transmission [see dosage and administration (2.3)]. the indication is based on a dosing regimen that included three components: - antepartum therapy of hiv-1 infected mothers - intrapartum therapy of hiv-1 infected mothers - post-partum therapy of hiv-1 exposed neonate points to consider prior to initiating zidovudine in pregnant women for the prevention of maternal-fetal hiv-1 transmission include: - in most cases, zidovudine for prevention of maternal-fetal hiv-1 transmission should be given in combination with other antiretroviral drugs. - prevention of hiv-1 transmission in women who have received zidovudine for a prolonged period before pregnancy has not been evaluated. - because the fetus is most susceptible to the potential teratogenic effects of drugs during the first 1

United States - English - NLM (National Library of Medicine)

doh central pharmacy - zidovudine (unii: 4b9xt59t7s) (zidovudine - unii:4b9xt59t7s) - zidovudine 300 mg - zidovudine tablets, a nucleoside reverse transcriptase inhibitor, are indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection. zidovudine tablets are indicated for the prevention of maternal-fetal hiv-1 transmission [see dosage and administration (2.2)].  the indication is based on a dosing regimen that included 3 components:   - antepartum therapy of hiv-1 infected mothers - intrapartum therapy of hiv-1 infected mothers - post-partum therapy of hiv-1 exposed neonate. points to consider prior to initiating zidovudine tablets in pregnant women for the prevention of maternal-fetal hiv-1 transmission include:   - in most cases, zidovudine tablets for prevention of maternal-fetal hiv-1 transmission should be given in combination with other antiretroviral drugs. - prevention of hiv-1 transmission in women who have received zidovudine tablets for a prolonged period before pregnancy has not been evaluated. - because the fetus is most susceptible to the potential teratogenic

United States - English - NLM (National Library of Medicine)

rebel distributors corp - zidovudine (unii: 4b9xt59t7s) (zidovudine - unii:4b9xt59t7s) - zidovudine 300 mg - zidovudine tablets, a nucleoside reverse transcriptase inhibitor, are indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection. zidovudine tablets are indicated for the prevention of maternal-fetal hiv-1 transmission [see dosage and administration (2.2)].  the indication is based on a dosing regimen that included 3 components:   - antepartum therapy of hiv-1 infected mothers - intrapartum therapy of hiv-1 infected mothers - post-partum therapy of hiv-1 exposed neonate. points to consider prior to initiating zidovudine tablets in pregnant women for the prevention of maternal-fetal hiv-1 transmission include:   - in most cases, zidovudine tablets for prevention of maternal-fetal hiv-1 transmission should be given in combination with other antiretroviral drugs. - prevention of hiv-1 transmission in women who have received zidovudine tablets for a prolonged period before pregnancy has not been evaluated. - because the fetus is most susceptible to the potential teratogenic eff

United States - English - NLM (National Library of Medicine)

camber pharmaceuticals, inc. - zidovudine (unii: 4b9xt59t7s) (zidovudine - unii:4b9xt59t7s) - zidovudine 300 mg - zidovudine tablets, a nucleoside reverse transcriptase inhibitor, are indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection. zidovudine tablets are indicated for the prevention of maternal-fetal hiv-1 transmission [see dosage and administration ( 2.3)]. the indication is based on a dosing regimen that included 3 components: 1. antepartum therapy of hiv-1-infected mothers 2. intrapartum therapy of hiv-1-infected mothers 3. post-partum therapy of hiv-1-exposed neonate points to consider prior to initiating zidovudine in pregnant women for the prevention of maternal-fetal hiv-1 transmission include: • in most cases, zidovudine for prevention of maternal-fetal hiv-1 transmission should be given in combination with other antiretroviral drugs. • prevention of hiv-1 transmission in women who have received zidovudine for a prolonged period before pregnancy has not been evaluated.

United States - English - NLM (National Library of Medicine)

cipla ltd. - zidovudine (unii: 4b9xt59t7s) (zidovudine - unii:4b9xt59t7s) - zidovudine 100 mg - zidovudine, a nucleoside reverse transcriptase inhibitor, is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection. zidovudine is indicated for the prevention of maternal-fetal hiv-1 transmission [see dosage and administration (2.3)] . the indication is based on a dosing regimen that included 3 components: - antepartum therapy of hiv-1-infected mothers - intrapartum therapy of hiv-1-infected mothers - post-partum therapy of hiv-1-exposed neonate points to consider prior to initiating zidovudine in pregnant women for the prevention of maternal-fetal hiv-1 transmission include: - in most cases, zidovudine for prevention of maternal-fetal hiv-1 transmission should be given in combination with other antiretroviral drugs. - prevention of hiv-1 transmission in women who have received zidovudine for a prolonged period before pregnancy has not been evaluated. - because the fetus is most susceptible to the potential teratogenic effects of drugs dur

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - zidovudine (unii: 4b9xt59t7s) (zidovudine - unii:4b9xt59t7s) - zidovudine 300 mg

United States - English - NLM (National Library of Medicine)

american health packaging - zidovudine (unii: 4b9xt59t7s) (zidovudine - unii:4b9xt59t7s) - zidovudine 300 mg

United States - English - NLM (National Library of Medicine)

edenbridge pharmaceuticals, llc - zidovudine (unii: 4b9xt59t7s) (zidovudine - unii:4b9xt59t7s) - zidovudine 50 mg in 5 ml

United States - English - NLM (National Library of Medicine)

american health packaging - zidovudine (unii: 4b9xt59t7s) (zidovudine - unii:4b9xt59t7s) - zidovudine 100 mg

United States - English - NLM (National Library of Medicine)

edenbridge pharmaceuticals, llc - zidovudine (unii: 4b9xt59t7s) (zidovudine - unii:4b9xt59t7s) - zidovudine 100 mg